| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.28 | 0.07 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |